EUVIMEDEUVIMED entdecken
Crossref

Causal effect of gut‐microbiota‐derived metabolite trimethylamine N‐oxide on Parkinson's disease: A Mendelian randomization study

Hang Zhou iD, Yuqi Luo, Wenjie Zhang, Fen Xie, Chao Deng iD, Wenhua Zheng, Shuzhen Zhu, Qing Wang iD

European Journal of Neurology · 2023

DOI: 10.1111/ene.15702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Hang Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Methylamines, Parkinson Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Guangdong Medical Science and Technology Research Foundation Project, Initiated Foundation of Zhujiang Hospital, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose It has been suggested that trimethylamine N‐oxide (TMAO) is related to Parkinson's disease (PD) in observational studies. However, the direction of this association is inconsistent. An exploratory Mendelian randomization study was conducted to investigate whether TMAO and its precursors have a causal relationship with PD. Methods Summary statistics were obtained for single nucleotide polymorphisms related to circulating levels of TMAO, betaine, carnitine and choline, and the corresponding data for the risk, age at onset and progression of PD from genome‐wide association studies. Inverse‐variance weighting was used as the primary method for effect estimation. The false discovery rate was applied to the correction of multiple testing. A p value of association

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesParkinson DiseaseGastrointestinal MicrobiomeHumansMendelian Randomization AnalysisPolymorphism, Single NucleotideCholineGenome-Wide Association StudyBetaineCarnitineMale

Stichwörter der Autor:innen

MendelianParkinson diseasecausal effectrandomization studytrimethylamine N-oxide

Substanzen

MethylaminestrimethyloxamineCholineBetaineCarnitine

Autor:innen und Institutionen

  • Department of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
  • School of Medical, Indigenous and Health Sciences, and Molecular Horizons, University of Wollongong, Wollongong, Australia.
  • Centre of Reproduction, Development and Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, China.

ORCID-Profile: Hang Zhou, Chao Deng, Qing Wang

Förderung

  • Guangdong Medical Science and Technology Research Foundation Project
  • Initiated Foundation of Zhujiang Hospital
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province of China
  • Science and Technology Program of Guangdong of China
  • Scientific Research Foundation of Guangzhou

Zitieren

APA

Zhou, H., Luo, Y., Zhang, W., Xie, F., Deng, C., Zheng, W., Zhu, S., & Wang, Q. (2023). Causal effect of gut‐microbiota‐derived metabolite trimethylamine N‐oxide on Parkinson's disease: A Mendelian randomization study. European Journal of Neurology. https://doi.org/10.1111/ene.15702

Vancouver

Zhou H, Luo Y, Zhang W, Xie F, Deng C, Zheng W, et al. Causal effect of gut‐microbiota‐derived metabolite trimethylamine N‐oxide on Parkinson's disease: A Mendelian randomization study. European Journal of Neurology. 2023. doi:10.1111/ene.15702

BibTeX
@article{Zhou2023,
  author = {Zhou, Hang and Luo, Yuqi and Zhang, Wenjie and Xie, Fen and Deng, Chao and Zheng, Wenhua and Zhu, Shuzhen and Wang, Qing},
  title = {Causal effect of gut‐microbiota‐derived metabolite trimethylamine N‐oxide on Parkinson's disease: A Mendelian randomization study},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15702}
}
Kostenlos starten →